Private Capital Group, LLC Acadia Pharmaceuticals Inc Transaction History

Private Capital Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 13, 2021	SELL	$15.78 - $24.77 $1,088 - $1,709	-69 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$19.4 - $27.42 $1,338 - $1,891	69 New	69 $2,000
Q3 2020 Nov 12, 2020	SELL	$36.42 - $57.0 $983 - $1,539	-27 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $977 - $1,387	27 New	27 $1,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.62B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Capital Group, LLC with notifications on news.